SEC Form 4 · accession 0001209191-16-125984
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ellen Rosenberg
Officer — General Counsel & Corp. Secy
Period of report
Jun 2, 2016
Accepted (ET)
Jun 6, 2016 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 2, 2016 | P | 15,000 | $7.67 | A | 15,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.66 to $7.67. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.